Michael Ruppert

Michael has 20 years’ experience in international business develop-ment in pharma, biotech, and medical device companies, and a long-standing track record as a seasoned deal-maker in the life science industry. He studied biology and holds a PhD in tumor immunology from the German Cancer Research Center in Heidelberg. He also received a MBA from Henley Management College, UK.